• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Glycochenodeoxycholic Acid

CAS No. 640-79-9

Glycochenodeoxycholic Acid ( Chenodeoxycholylglycine )

产品货号. M18944 CAS No. 640-79-9

Glycolithocholic acid is a glycine conjugate of lithocholic acid, a bile acid. It is increased in livers of mice that are fed diets supplemented with ursadeoxycholic acid.

纯度: 97%

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥243 有现货
10MG ¥381 有现货
25MG ¥616 有现货
50MG ¥907 有现货
100MG ¥1337 有现货
200MG ¥1985 有现货
500MG ¥3370 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Glycochenodeoxycholic Acid
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Glycolithocholic acid is a glycine conjugate of lithocholic acid, a bile acid. It is increased in livers of mice that are fed diets supplemented with ursadeoxycholic acid.
  • 产品描述
    Glycolithocholic acid is a glycine conjugate of lithocholic acid, a bile acid. It is increased in livers of mice that are fed diets supplemented with ursadeoxycholic acid. Glycolithocholic acid levels are decreased in lean mice treated with obestatin. Serum glycolithocholic acid levels increase with age in children.
  • 同义词
    Chenodeoxycholylglycine
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    Others
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    640-79-9
  • 分子量
    449.62
  • 分子式
    C26H43NO5
  • 纯度
    97%
  • 溶解度
    DMSO : ≥ 29 mg/mL; 64.50 mM
  • SMILES
    O=C(O)CNC(=O)CC[C@@H](C)[C@H]4CC[C@@H]1[C@]4(C)CC[C@@H]2[C@@]3(C)CC[C@@H](O)C[C@H]3C[C@@H](O)[C@@H]12
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Kuipers F, Derksen JP, Gerding A, Scherphof GL, Vonk RJ. Biochim Biophys Acta. 1987 Nov 21;922(2):136-44.
产品手册
关联产品
  • Bacopaside I

    Bacopaside I is a saponin isolated from Bacopa monniera.?Bacopaside I is a modulator of Aquaporin-1 channel, has neuroprotective functions, it has anti-Alzheimer's disease.

  • Moracin O

    Moracin O shows significant neuroprotective, and analgesic activities, it also has a strong protective influence against doxorubicin-induced cardiomyopathy in H9c2 cells with the EC50 value of 4.5 ± 1.3 μM.

  • pep2-AVKI

    Inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD).